Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
25 03 2021
Historique:
received: 14 06 2020
accepted: 14 09 2020
pubmed: 25 10 2020
medline: 21 10 2021
entrez: 24 10 2020
Statut: ppublish

Résumé

The prevalence of obesity is burgeoning among African American and Latina women; however, few studies investigating the skeletal effects of bariatric surgery have focused on these groups. To investigate long-term skeletal changes following Roux-en-Y gastric bypass (RYGB) in African American and Latina women. Four-year prospective cohort study. African American and Latina women presenting for RYGB (n = 17, mean age 44, body mass index 44 kg/m2) were followed annually for 4 years postoperatively. Dual-energy x-ray absorptiometry (DXA) measured areal bone mineral density (aBMD) at the spine, hip, and forearm, and body composition. High-resolution peripheral quantitative computed tomography measured volumetric bone mineral density (vBMD) and microarchitecture. Individual trabecula segmentation-based morphological analysis assessed trabecular morphology and connectivity. Baseline DXA Z-Scores were normal. Weight decreased ~30% at Year 1, then stabilized. Parathyroid hormone (PTH) increased by 50% and 25-hydroxyvitamin D was stable. By Year 4, aBMD had declined at all sites, most substantially in the hip. There was significant, progressive loss of cortical and trabecular vBMD, deterioration of microarchitecture, and increased cortical porosity at both the radius and tibia over 4 years. There was loss of trabecular plates, loss of axially aligned trabeculae, and decreased trabecular connectivity. Whole bone stiffness and failure load declined. Risk factors for bone loss included greater weight loss, rise in PTH, and older age. African American and Latina women had substantial and progressive bone loss, deterioration of microarchitecture, and trabecular morphology following RYGB. Further studies are critical to understand the long-term skeletal consequences of bariatric surgery in this population.

Identifiants

pubmed: 33098299
pii: 5906394
doi: 10.1210/clinem/dgaa654
pmc: PMC8502471
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1868-e1879

Subventions

Organisme : NIDDK NIH HHS
ID : K24 DK074457
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Obes Rev. 2018 May;19(5):728-736
pubmed: 29334691
J Clin Endocrinol Metab. 2008 Mar;93(3):861-8
pubmed: 18160467
J Bone Miner Res. 2016 Mar;31(3):672-82
pubmed: 26350034
Ann N Y Acad Sci. 2010 Mar;1192:66-71
pubmed: 20392219
J Bone Miner Res. 2013 Oct;28(10):2177-85
pubmed: 23572415
Osteoporos Int. 2011 May;22(5):1377-88
pubmed: 20737265
Int J Obes (Lond). 2005 Dec;29(12):1429-35
pubmed: 16077715
J Bone Miner Res. 2012 Feb;27(2):263-72
pubmed: 22072446
J Bone Miner Res. 2010 Jan;25(1):64-71
pubmed: 19580459
J Bone Miner Res. 2011 Feb;26(2):263-9
pubmed: 20715186
Eur J Endocrinol. 2020 Mar;182(3):303-311
pubmed: 31940278
J Clin Endocrinol Metab. 2014 Nov;99(11):4231-40
pubmed: 25127089
J Bone Miner Res. 2012 Mar;27(3):619-27
pubmed: 22354851
Obes Surg. 2011 Apr;21(4):465-72
pubmed: 21188546
J Bone Miner Res. 2006 Oct;21(10):1608-17
pubmed: 16995816
Eur J Endocrinol. 2017 Jun;176(6):685-693
pubmed: 28289103
J Clin Endocrinol Metab. 2008 Oct;93(10):3735-40
pubmed: 18647809
J Biomech. 2009 Feb 9;42(3):249-56
pubmed: 19101672
Med Eng Phys. 2007 Dec;29(10):1096-105
pubmed: 17229586
BMJ. 2016 Jul 27;354:i3794
pubmed: 27814663
J Bone Miner Res. 2011 Aug;26(8):1783-92
pubmed: 21351150
Obesity (Silver Spring). 2006 Nov;14(11):1940-8
pubmed: 17135609
J Bone Miner Res. 2012 Jan;27(1):119-24
pubmed: 21915902
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4104-4112
pubmed: 30219833
Am J Clin Nutr. 1999 Jul;70(1):97-103
pubmed: 10393145
N Engl J Med. 2007 Aug 23;357(8):753-61
pubmed: 17715409
Bone. 1999 Jan;24(1):35-9
pubmed: 9916782
Osteoporos Int. 2016 Oct;27(10):2955-66
pubmed: 27155883
J Bone Miner Res. 2010 Jul;25(7):1496-505
pubmed: 20200967
N Engl J Med. 2007 Aug 23;357(8):741-52
pubmed: 17715408
Obes Res. 2004 Jan;12(1):40-7
pubmed: 14742841
J Clin Densitom. 2003 Fall;6(3):199-204
pubmed: 14514987
Osteoporos Int. 2014 Jan;25(1):151-8
pubmed: 23912559
J Bone Miner Res. 2020 Nov;35(11):2132-2142
pubmed: 32663365
J Clin Endocrinol Metab. 2015 Apr;100(4):1452-9
pubmed: 25646793
J Clin Endocrinol Metab. 2019 Mar 1;104(3):711-720
pubmed: 30657952
Surg Endosc. 2018 Jun;32(6):2650-2655
pubmed: 29713829
J Bone Miner Res. 2018 Jun;33(6):975-986
pubmed: 29281126
JAMA. 2012 Jan 4;307(1):56-65
pubmed: 22215166
Obesity (Silver Spring). 2015 Dec;23(12):2344-8
pubmed: 26193177
Bone. 2015 May;74:140-5
pubmed: 25603463
J Bone Miner Res. 2005 Mar;20(3):455-63
pubmed: 15746990
J Bone Miner Res. 2012 Jan;27(1):1-10
pubmed: 23348758
J Bone Miner Res. 2015 Aug;30(8):1377-85
pubmed: 25640580
Bone. 2017 Feb;95:85-90
pubmed: 27871812
Obes Surg. 2017 Sep;27(9):2279-2289
pubmed: 28405878
JAMA Surg. 2016 Nov 1;151(11):1046-1055
pubmed: 27579793
Trans Am Clin Climatol Assoc. 2007;118:305-15
pubmed: 18528512
J Clin Endocrinol Metab. 2013 Feb;98(2):541-9
pubmed: 23295461
Am J Med. 2009 Mar;122(3):248-256.e5
pubmed: 19272486
JAMA Surg. 2014 Mar;149(3):275-87
pubmed: 24352617
Obes Surg. 2016 Jan;26(1):91-7
pubmed: 25982806
J Clin Endocrinol Metab. 2004 Mar;89(3):1061-5
pubmed: 15001587
Bone. 2007 Oct;41(4):505-15
pubmed: 17693147
J Bone Miner Res. 2010 Apr;25(4):882-90
pubmed: 19839766
Obes Surg. 2009 Jul;19(7):860-6
pubmed: 19412643
J Clin Densitom. 2012 Jul-Sep;15(3):315-9
pubmed: 22402120
Medicine (Baltimore). 2015 Dec;94(48):e2087
pubmed: 26632892
J Bone Miner Res. 2008 Feb;23(2):223-35
pubmed: 17907921
Bone. 2010 Sep;47(3):519-28
pubmed: 20561906
J Bone Miner Res. 2013 Jun;28(6):1308-18
pubmed: 23299863
Obesity (Silver Spring). 2013 Mar;21 Suppl 1:S1-27
pubmed: 23529939
J Bone Miner Res. 2017 Jun;32(6):1229-1236
pubmed: 28251687
N Engl J Med. 2012 Apr 26;366(17):1567-76
pubmed: 22449319
J Bone Miner Res. 2010 Apr;25(4):746-56
pubmed: 19775199
BMJ. 2012 Aug 03;345:e5085
pubmed: 22867649
J Bone Miner Res. 2010 Dec;25(12):2572-81
pubmed: 20564238
N Engl J Med. 2012 Apr 26;366(17):1577-85
pubmed: 22449317
Bone Res. 2014 Sep 16;2:14016
pubmed: 26273525

Auteurs

Alexandra Krez (A)

Endocrinology and Metabolic Bone Disease Service, Hospital for Special Surgery, New York, New York.

Sanchita Agarwal (S)

Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.

Mariana Bucovsky (M)

Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.

Donald J McMahon (DJ)

Endocrinology and Metabolic Bone Disease Service, Hospital for Special Surgery, New York, New York.
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.

Yizhong Hu (Y)

Bone Bioengineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, New York.

Marc Bessler (M)

Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY.

Beth Schrope (B)

Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY.

Angela Carrelli (A)

Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.

Shannon Clare (S)

Endocrinology and Metabolic Bone Disease Service, Hospital for Special Surgery, New York, New York.

Xiang-Dong Edward Guo (XE)

Bone Bioengineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, New York.

Shonni J Silverberg (SJ)

Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.

Emily M Stein (EM)

Endocrinology and Metabolic Bone Disease Service, Hospital for Special Surgery, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH